Werfen Spain and Portugal Revenue and Competitors
Employee Data
- Werfen Spain and Portugal has 42 Employees.
- Werfen Spain and Portugal grew their employee count by 75% last year.
Werfen Spain and Portugal's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Information Officer | Reveal Email/Phone |
2 | VP Research and Development / Business Development | Reveal Email/Phone |
3 | VP Corporate Controller | Reveal Email/Phone |
4 | VP R&D Transplant | Reveal Email/Phone |
5 | VP & General Counsel | Reveal Email/Phone |
6 | VP, Global Supply Chain | Reveal Email/Phone |
7 | Director, Manufacturing Engineering and Process Support | Reveal Email/Phone |
8 | Director, European Supply Chain Ops. | Reveal Email/Phone |
9 | Senior Director, Mfg Technical Support & Validation | Reveal Email/Phone |
10 | Area Business Director | Central U.S. | Reveal Email/Phone |
Werfen Spain and Portugal Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 36 | 57% | N/A | N/A |
#2 | N/A | 34 | 31% | N/A | N/A |
#3 | N/A | 42 | 75% | N/A | N/A |
What Is Werfen Spain and Portugal?
Somos Werfen.\n\nLíder mundial en diagnóstico especializado en Hemostasia, Acute Care y Autoinmunidad. A través de nuestra línea de negocio OEM, investigamos, desarrollamos y fabricamos ensayos y biomateriales personalizados.\n\nSomos um líder mundial no diagnóstico especializado nas especialidades de hemostasia, Acute Care Diagnostics e autoimunidade. Através da nossa linha de negócio OEM, investigamos, desenvolvemos e fabricamos ensaios personalizados e biomateriais.
keywords:N/A
N/A
Total Funding
42
Number of Employees
N/A
Revenue (est)
75%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Hospitalet de Llobregat
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.7M | 46 | 31% | N/A |
#2 | $12.3M | 85 | 81% | N/A |
#3 | N/A | 90 | 41% | N/A |
#4 | $7.5M | 98 | -7% | N/A |
#5 | $67.4M | 250 | 7% | N/A |